Becker's Healthcare September 24, 2024
On Sept. 23, the Federal Trade Commission published a redacted lawsuit it recently filed against three pharmacy benefit managers and group purchasing organizations. Here is what to know:
1. The lawsuit accuses the nation’s three largest PBMs and their GPOs of inflating insulin prices through alleged anticompetitive practices. “These behemoth PBMs came to exert enormous influence over drug pricing and purchasing decisions” as they work between drug manufacturers, payers and pharmacies, according to the suit.
2. The defendants are CVS Health’s Caremark and its GPO, Zinc Health Services; UnitedHealth Group’s Optum Rx and its GPO, Ascent Health Services; and Cigna Group’s Express Scripts/Evernorth Health and their GPOs, Medco Health Services/Ascent Health Services.
3. In response to the lawsuit, CVS...
Today's Sponsors
Today's Sponsor